Seroatlas · Human Serome Atlas

TSGA13

Testis-specific gene 13 protein

Also known as: TSG13_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q96PP4
Gene
TSGA13
Ensembl
ENSG00000213265
Chromosome
7
Canonical length
275 aa
Protein class
Predicted intracellular proteins
Subcellular location
Vesicles,Plasma membrane,Cytosol

OverviewNCBI Gene

No narrative summary is available for TSGA13 in this catalog release; identity and structured annotations are shown without generated factual claims.

Canonical amino-acid sequenceUniProt

275 residues, UniProt reviewed canonical sequence.

>Q96PP4|TSGA13
     1  MSQKRQTKFQ NGKSKTSENS SAKREKGMVV NSKEISDAVG QSKFVLENLR HYTVHPNLAQ
    61  YYKPLKATAL QKFLAQNRKN TSFMLKVTQY DQDKTLLIMT NNPPPCSITQ QDKESASKYF
   121  SKELLLKVME SHHQHKPTEN LWLPRMPQKK KLRSKLKPIF PLILSDDPTS KREQWFRFST
   181  DNDFKSEGKY SKVYALRTQK KMYPQLTFAP VHERDMRKDA SKKSASERPI SKVIREPLTL
   241  ASLLEDMPTR TAPGESAFRN GRAPQWIIKK ATVIG

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against TSGA13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Unknown
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.65
Highest tissue expression
12 nTPM

Expression across tissuesHPA

Tissue

  • testis: 12 nTPM
  • fallopian tube: 0.1 nTPM
  • adipose tissue: 0 nTPM
  • adrenal gland: 0 nTPM
  • amygdala: 0 nTPM
  • appendix: 0 nTPM

Single-cell type

  • late spermatids: 385 nCPM
  • late primary spermatocytes: 75 nCPM
  • early spermatids: 73 nCPM
  • cholangiocytes: 2 nCPM
  • foveolar cells: 1.5 nCPM
  • adipocytes: 1.2 nCPM

Immune cell

  • basophil: 0.1 nTPM
  • neutrophil: 0.1 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM

Brain region

  • basal ganglia: 0.5 nTPM
  • cerebellum: 0.5 nTPM
  • hypothalamus: 0.5 nTPM
  • amygdala: 0.4 nTPM
  • cerebral cortex: 0.4 nTPM
  • medulla oblongata: 0.4 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.56
gnomAD pLI
0
gnomAD missense Z
-0.47
DepMap mean gene effect
-0.02
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

Protein domainsUniProt · Pfam · InterPro

  • Testis-specific gene 13 protein
  • Testis-specific gene 13 protein

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads TSGA13 as an antibody target. Whether an autoantibody or antibody against TSGA13 could matter depends on whether native TSGA13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

TSGA13 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label TSGA13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/TSGA13. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...